Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Wiśniowska

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2018
Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling studyBarbara Wiśniowska, Sebastian Polak
Toxicology Mechanisms and Methods|September 26, 2009
hERG in vitro interchange factors--development and verificationBarbara Wiśniowska, Sebastian Polak
Drug Discovery Today|October 9, 2016
Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensityBarbara Wiśniowska, Sebastian Polak
Current Pharmacology Reports|December 6, 2016
The Role of Interaction Model in Simulation of Drug Interactions and QT ProlongationBarbara Wiśniowska, Sebastian Polak
Journal of Pharmaceutical Sciences|September 20, 2016
Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an ExampleBarbara Wiśniowska, Sebastian Polak
Journal of Applied Toxicology : JAT|November 7, 2008
Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic propertiesSebastian Polak, Barbara Wiśniowska, Jerzy Brandys
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 22, 2024
Towards the understanding of the IVPT results variability-Development, verification and validation of the PBPK model of caffeine in vitro human skin permeationLaura Krumpholz, Sebastian Polak, Barbara Wiśniowska
BMC Pharmacology & Toxicology|January 11, 2022
Open-access database of literature derived drug-related Torsade de Pointes casesLaura Krumpholz, Barbara Wiśniowska, Sebastian Polak
Current Pharmacology Reports|July 19, 2016
Top-down, Bottom-up and Middle-out Strategies for Drug Cardiac Safety Assessment via Modeling and SimulationsZofia Tylutki, Sebastian Polak, Barbara Wiśniowska
International Journal of Pharmaceutics|September 15, 2025
Use of PBPK modelling to extrapolate in vitro porcine ear skin permeability to in vivo human dermal absorptionLaura Krumpholz, Sebastian Polak, Barbara Wiśniowska
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2018
Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling studyBarbara Wiśniowska, Sebastian Polak
Toxicology Mechanisms and Methods|September 26, 2009
hERG in vitro interchange factors--development and verificationBarbara Wiśniowska, Sebastian Polak
Drug Discovery Today|October 9, 2016
Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensityBarbara Wiśniowska, Sebastian Polak
Current Pharmacology Reports|December 6, 2016
The Role of Interaction Model in Simulation of Drug Interactions and QT ProlongationBarbara Wiśniowska, Sebastian Polak
Journal of Pharmaceutical Sciences|September 20, 2016
Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an ExampleBarbara Wiśniowska, Sebastian Polak
Journal of Applied Toxicology : JAT|November 7, 2008
Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic propertiesSebastian Polak, Barbara Wiśniowska, Jerzy Brandys
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 22, 2024
Towards the understanding of the IVPT results variability-Development, verification and validation of the PBPK model of caffeine in vitro human skin permeationLaura Krumpholz, Sebastian Polak, Barbara Wiśniowska
BMC Pharmacology & Toxicology|January 11, 2022
Open-access database of literature derived drug-related Torsade de Pointes casesLaura Krumpholz, Barbara Wiśniowska, Sebastian Polak
Current Pharmacology Reports|July 19, 2016
Top-down, Bottom-up and Middle-out Strategies for Drug Cardiac Safety Assessment via Modeling and SimulationsZofia Tylutki, Sebastian Polak, Barbara Wiśniowska
International Journal of Pharmaceutics|September 15, 2025
Use of PBPK modelling to extrapolate in vitro porcine ear skin permeability to in vivo human dermal absorptionLaura Krumpholz, Sebastian Polak, Barbara Wiśniowska
Pageof 4